T Cell Fate at the Single-Cell Level

Annual Review of Immunology

Volumn 34, Issue , 2016, Pages 65-92

  Buchholz, Veit R ^a   Schumacher, Ton N M ^b   Busch, Dirk H ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Immunotherapy; Robustness; Stemness; Stochasticity; T cell differentiation; T cell memory

Indexed keywords

EPITOPE;

ADAPTIVE IMMUNITY; ADULT STEM CELL; ARTICLE; ASYMMETRIC CELL DIVISION; CELL CYCLE; CELL DIFFERENTIATION; CELL FATE; CELL REGENERATION; CELL SPECIFICITY; CELLULAR IMMUNITY; HUMAN; IMMUNOTHERAPY; MEMORY T LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STOCHASTIC MODEL; T LYMPHOCYTE; ANIMAL; BIODIVERSITY; CELL LINEAGE; CELL PROLIFERATION; CULTURAL DIVERSITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PROCEDURES; SINGLE CELL ANALYSIS;

ADULT STEM CELLS; ANIMALS; BIODIVERSITY; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CULTURAL DIVERSITY; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; SINGLE-CELL ANALYSIS; T-LYMPHOCYTES;

EID: 84969822523     PISSN: 07320582     EISSN: 15453278     Source Type: Book Series    
DOI: 10.1146/annurev-immunol-032414-112014     Document Type: Article

References (170)

1. Maus MV, Fraietta JA, Levine BL, Kalos M, Zhao Y, June CH. 2014. Adoptive immunotherapy for cancer or viruses. Annu. Rev. Immunol. 32:189-225
2. Rosenberg SA, Restifo NP. 2015. Adoptive cell transfer as personalized immunotherapy for human cancer. Science 348(6230):62-68
3. Jensen MC, Riddell SR. 2014. Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells. Immunol. Rev. 257(1):127-44
4. WilliamsMA, BevanMJ. 2007. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25:171-92
5. Zhu J, Yamane H, Paul WE. 2010. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28:445-89
6. Nikolich-Zugich J, Slifka MK, Messaoudi I. 2004. The many important facets of T-cell repertoire diversity. Nat. Rev. Immunol. 4(2):123-32
7. JenkinsMK, Chu HH, McLachlan JB,Moon JJ. 2010. On the composition of the preimmune repertoire of T cells specific for peptide-major histocompatibility complex ligands. Annu. Rev. Immunol. 28:275-94
8. Burnet SFM. 1957. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust. J. Sci. 20(3):67-69
9. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291(5512):2413-17
10. Sung JH, Zhang H, Moseman EA, Alvarez D, Iannacone M, et al. 2012. Chemokine guidance of central memory T cells is critical for antiviral recall responses in lymph nodes. Cell 150(6):1249-63
11. Kaech SM, Hemby S, Kersh E, Ahmed R. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111(6):837-51
12. Wolint P, Betts MR, Koup RA, Oxenius A. 2004. Immediate cytotoxicity but not degranulation distinguishes effector and memory subsets of CD8+ T cells. J. Exp. Med. 199(7):925-36
13. Buchholz VR, Graf P, Busch DH. 2012. The origin of diversity: studying the evolution of multi-faceted CD8+ T cell responses. Cell Mol. Life Sci. 69(10):1585-95
14. Jameson SC, Masopust D. 2009. Diversity in T cell memory: an embarrassment of riches. Immunity 31(6):859-71
15. Darrah PA, Patel DT, De Luca PM, Lindsay RWB, Davey DF, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13(7):843-50
16. Seder RA, Darrah PA, Roederer M. 2008. T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8(4):247-58
17. Appay V, Dunbar PR, Callan M, Klenerman P, Gillespie GMA, et al. 2002. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8(4):379-85
18. Appay V, Douek DC, Price DA. 2008. CD8+ T cell efficacy in vaccination and disease. Nat. Med. 14(6):623-28
19. Hulett HR, BonnerWA, Barrett J, Herzenberg LA. 1969. Cell sorting: automated separation of mammalian cells as a function of intracellular fluorescence. Science 166(3906):747-49
20. Parks DR, Hardy RR, Herzenberg LA. 1984. Three-color immunofluorescence analysis of mouse Blymphocyte subpopulations. Cytometry 5(2):159-68
21. De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 2001. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med. 7(2):245-48
22. Schmitz J, Assenmacher M, RadbruchA. 1993. Regulation ofThelper cell cytokine expression: functional dichotomy of antigen-presenting cells. Eur. J. Immunol. 23(1):191-99
23. Jung T, Schauer U, Heusser C, Neumann C, Rieger C. 1993. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159(1-2):197-207
24. Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, et al. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182(5):1357-67
25. Manz R, Assenmacher M, Pfl uger E, Miltenyi S, Radbruch A. 1995. Analysis and sorting of live cells according to secreted molecules, relocated to a cell-surface affinity matrix. PNAS 92(6):1921-25
26. Jacob J, Baltimore D. 1999. Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399(6736):593-97
27. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud O, et al. 2004. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118(2):217-28
28. Newell EW, Sigal N, Bendall SC, Nolan GP, Davis MM. 2012. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36(1):142-52
29. Shalek AK, Satija R, Adiconis X, Gertner RS, Gaublomme JT, et al. 2013. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 498(7453):236-40
30. Mosmann TR, Cherwinski H, BondMW, Giedlin MA, Coffman RL. 1986. Two types of murine helper Tcell clone. I.Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136(7):2348-57
31. Sallusto F, Lenig D, F orster R, Lipp M, Lanzavecchia A. 1999. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401(6754):708-12
32. Gebhardt T, Wakim LM, Eidsmo L, Reading PC, Heath WR, Carbone FR. 2009. Memory T cells in nonlymphoid tissue that provide enhanced local immunity during infection with herpes simplex virus. Nat. Immunol. 10(5):524-30
33. Gebhardt T, Whitney PG, Zaid A, Mackay LK, Brooks AG, et al. 2011. Different patterns of peripheral migration by memory CD4+ and CD8+ T cells. Nature 477(7363):216-19
34. Steinert EM, Schenkel JM, Fraser KA, Beura LK, Manlove LS, et al. 2015. Quantifying memory CD8 T cells reveals regionalization of immunosurveillance. Cell 161(4):737-49
35. King IL, Mohrs M. 2009. IL-4-producing CD4+ T cells in reactive lymph nodes during helminth infection are T follicular helper cells. J. Exp. Med. 206(5):1001-7
36. Glatman Zaretsky A, Taylor JJ, King IL, Marshall FA, Mohrs M, Pearce EJ. 2009. T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J. Exp. Med. 206(5):991-99
37. Nakayamada S, Kanno Y, Takahashi H, Jankovic D, Lu KT, et al. 2011. Early Th1 cell differentiation is marked by a Tfh cell-like transition. Immunity 35(6):919-31
38. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12(3):255-63
39. Pepper M, Pagan AJ, Igyart o BZ, Taylor JJ, Jenkins MK. 2011. Opposing signals from the Bcl6 transcription factor and the interleukin-2 receptor generate T helper 1 central and effector memory cells. Immunity 35(4):583-95
40. Pepper M, Jenkins MK. 2011. Origins of CD4+ effector and central memory T cells. Nat. Immunol. 131(6):467-71
41. Kaech SM, Tan JT,Wherry EJ, Konieczny BT, Surh CD, Ahmed R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4(12):1191-98
42. Huster KM, Busch V, Schiemann M, Linkemann K, Kerksiek KM, et al. 2004. Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets. PNAS 101(15):5610-15
43. Schluns KS, Williams K,Ma A, Zheng XX, Lefrancois L. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168(10):4827-31
44. Goldrath AW, Sivakumar PV, Glaccum M, Kennedy MK, Bevan MJ, et al. 2002. Cytokine requirements for acute and basal homeostatic proliferation of naive and memory CD8+ T cells. J. Exp. Med. 195(12):1515-22
45. Becker TC,Wherry EJ, Boone D,Murali-Krishna K, Antia R, et al. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195(12):1541-48
46. Obar JJ, Jellison ER, Sheridan BS, Blair DA, Pham Q-M, et al. 2011. Pathogen-induced inflammatory environment controls effector and memory CD8+ T cell differentiation. J. Immunol. 187(10):4967-78
47. Newell EW, Davis MM. 2014. Beyond model antigens: high-dimensional methods for the analysis of antigen-specific T cells. Nat. Biotechnol. 32(2):149-57
48. FlatzL,RoychoudhuriR,Honda M, Filali-Mouhim A, Goulet JP, et al. 2011. Single-cell gene-expression profiling reveals qualitatively distinct CD8 T cells elicited by different gene-based vaccines. PNAS 108(14):5724-29
49. Harty JT, Badovinac VP. 2008. Shaping and reshaping CD8+ T-cell memory. Nat. Rev. Immunol. 8(2):107-19
50. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. 1999. A direct estimate of the human αβT cell receptor diversity. Science 286(5441):958-61
51. Casrouge A, Beaudoing E, Dalle S, Pannetier C, Kanellopoulos J, Kourilsky P. 2000. Size estimate of the αβTCR repertoire of naive mouse splenocytes. J. Immunol. 164(11):5782-87
52. Blattman JN,Antia R, Sourdive DJD,WangX, Kaech SM, et al. 2002. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195(5):657-64
53. Badovinac VP, Haring JS, Harty JT. 2007. Initial T cell receptor transgenic cell precursor frequency dictates critical aspects of the CD8+ T cell response to infection. Immunity 26(6):827-41
54. Obar JJ, Khanna KM, Lefrancois L. 2008. Endogenous naiveCD8+ Tcell precursor frequency regulates primary and memory responses to infection. Immunity 28(6):859-69
55. Jenkins MK, Moon JJ. 2012. The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude. J. Immunol. 188(9):4135-40
56. Heijst JWJ, Gerlach C, Swart E, Sie D, Nunes-Alves C, et al. 2009. Recruitment of antigen-specific CD8+ T cells in response to infection is markedly efficient. Science 325(5945):1265-69
57. Reiner SL, Sallusto F, Lanzavecchia A. 2007. Division of labor with a workforce of one: challenges in specifying effector and memory T cell fate. Science 317(5838):622-25
58. Zehn D, Lee SY, Bevan MJ. 2009. Complete but curtailed T-cell response to very low-affinity antigen. Nature 458(7235):211-14
59. Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG. 2009. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat. Immunol. 10(4):375-84
60. Feinerman O, Veiga J, Dorfman JR, Germain RN, Altan-Bonnet G. 2008. Variability and robustness in T cell activation from regulated heterogeneity in protein levels. Science 321(5892):1081-84
61. Raser JM, O'Shea EK. 2005. Noise in gene expression: origins, consequences, and control. Science 309(5743):2010-13
62. Chang HH, HembergM, BarahonaM, Ingber DE, Huang S. 2008. Transcriptome-wide noise controls lineage choice in mammalian progenitor cells. Nature 453(7194):544-47
63. Eldar A, Elowitz MB. 2010. Functional roles for noise in genetic circuits. Nature 467(7312):167-73
64. Schumacher TNM, Gerlach C, Heijst JWJ. 2010. Mapping the life histories of T cells. Nat. Rev. Immunol. 10(9):621-31
65. Gaide O, Emerson RO, Jiang X, Gulati N, Nizza S, et al. 2015. Common clonal origin of central and resident memory T cells following skin immunization. Nat. Med. 21(6):647-53
66. KastenmullerW, Brandes M, Wang Z, Herz J, Egen JG, Germain RN. 2013. Peripheral prepositioning and local CXCL9 chemokine-mediated guidance orchestrate rapid memory CD8+ T cell responses in the lymph node. Immunity 38(3):502-13
67. Beuneu H, Lemaître F, Deguine J, Moreau HD, Bouvier I, et al. 2010. Visualizing the functional diversification of CD8+ T cell responses in lymph nodes. Immunity 33(3):412-23
68. Livet J, Weissman TA, Kang H, Draft RW, Lu J, et al. 2007. Transgenic strategies for combinatorial expression of fluorescent proteins in the nervous system. Nature 450(7166):56-62
69. Cai D, Cohen KB, Luo T, Lichtman JW, Sanes JR. 2013. Improved tools for the Brainbow toolbox. Nat. Methods 10(6):540-47
70. Snippert HJ, van Flier LG, Sato T, Es JH, BornM,et al. 2010. Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells. Cell 143(1):134-44
71. Simons BD, Clevers H. 2011. Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 145(6):851-62
72. Weber K, Thomaschewski M, Warlich M, Volz T, Cornils K, et al. 2011. RGB marking facilitates multicolor clonal cell tracking. Nat. Med. 17(4):504-9
73. Martinez RJ,NeeldDK, Evavold BD. 2015. Identification of T cell clones without the need for sequencing. J. Immunol. Methods 424:28-31
74. Schepers K, Swart E, van Heijst JW, Gerlach C, Castrucci M, et al. 2008. Dissecting T cell lineage relationships by cellular barcoding. J. Exp. Med. 205(10):2309-18
75. Gerlach C, van Heijst JWJ, Swart E, Sie D, Armstrong N, et al. 2010. One naive T cell, multiple fates in CD8+ T cell differentiation. J. Exp. Med. 207(6):1235-46
76. Gerlach C, Rohr JC, Perie L, van Rooij N, van Heijst JWJ, et al. 2013. Heterogeneous differentiation patterns of individual CD8+ T cells. Science 340(6132):635-39
77. Stemberger C, Huster KM, KofflerM, Anderl F, Schiemann M, et al. 2007. A single naive CD8+ T cell precursor can develop into diverse effector and memory subsets. Immunity 27(6):985-97
78. Buchholz VR, FlossdorfM,Hensel I, Kretschmer L,Weissbrich B, et al. 2013. Disparate individual fates compose robust CD8+ T cell immunity. Science 340(6132):630-35
79. Graef P, Buchholz VR, Stemberger C, FlossdorfM, Henkel L, et al. 2014. Serial transfer of single-cellderived immunocompetence reveals stemness of CD8+ central memory T cells. Immunity 41(1):116-26
80. Tubo NJ, Pagan AJ, Taylor JJ, Nelson RW, Linehan JL, et al. 2013. Single naive CD4+ T cells from a diverse repertoire produce different effector cell types during infection. Cell 153(4):785-96
81. PlumleeCR, SheridanBS, Cicek BB, Lefrancois L. 2013. Environmental cues dictate the fate of individual CD8+ T cells responding to infection. Immunity 39(2):347-56
82. Buchholz VR, Graf P, Busch DH. 2013. The smallest unit: effector and memory CD8+ T cell differentiation on the single cell level. Front. Immunol. 4:31
83. Rohr JC, Gerlach C, Kok L, Schumacher TN. 2014. Single cell behavior in T cell differentiation. Trends Immunol. 35(4):170-77
84. Schroeder T. 2008. Imaging stem-cell-driven regeneration in mammals. Nature 453(7193):345-51
85. Eilken HM, Nishikawa S-I, Schroeder T. 2009. Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature 457(7231):896-900
86. Rieger MA, Hoppe PS, Smejkal BM, Eitelhuber AC, Schroeder T. 2009. Hematopoietic cytokines can instruct lineage choice. Science 325(5937):217-18
87. Duffy KR, Wellard CJ, Markham JF, Zhou JHS, Holmberg R, et al. 2012. Activation-induced B cell fates are selected by intracellular stochastic competition. Science 335(6066):338-41
88. Kinjyo I, Qin J, Tan S-Y,Wellard CJ, Mrass P, et al. 2015. Real-time tracking of cell cycle progression during CD8+ effector and memory T-cell differentiation. Nat. Commun. 6:6301
89. Joshi NS, CuiW, Chandele A, Lee HK, Urso DR, et al. 2007. Inflammation directs memory precursor and short-lived effector CD8+ T cell fates via the graded expression of T-bet transcription factor. Immunity 27(2):281-95
90. Sarkar S, Kalia V, Haining WN, Konieczny BT, Subramaniam S, Ahmed R. 2008. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205(3):625-40
91. Bannard O, Kraman M, Fearon DT. 2009. Secondary replicative function of CD8+ T cells that had developed an effector phenotype. Science 323(5913):505-9
92. Harrington LE, Janowski KM, Oliver JR, Zajac AJ, Weaver CT. 2008. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 452(7185):356-60
93. Intlekofer AM,TakemotoN,Wherry EJ, Longworth SA, Northrup JT, et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6(12):1236-44
94. Stefanova I, Dorfman JR, Germain RN. 2002. Self-recognition promotes the foreign antigen sensitivity of naive T lymphocytes. Nature 420(6914):429-34
95. Hochweller K, Wabnitz GH, Samstag Y, Suffner J, Hammerling GJ, Garbi N. 2010. Dendritic cells control T cell tonic signaling required for responsiveness to foreign antigen. PNAS 107(13):5931-36
96. Mandl JN, Monteiro JP, Vrisekoop N, Germain RN. 2013. T cell-positive selection uses self-ligand binding strength to optimize repertoire recognition of foreign antigens. Immunity 38(2):263-74
97. Fulton RB, Hamilton SE, Xing Y, Best JA, Goldrath AW, et al. 2014. The TCR's sensitivity to self peptide-MHC dictates the ability of naive CD8+ T cells to respond to foreign antigens. Nat. Immunol. 16(1):107-17
98. Baron V, Bouneaud C, Cumano A, Lim A, Arstila TP, et al. 2003. The repertoires of circulating human CD8+ central and effector memory T cell subsets are largely distinct. Immunity 18(2):193-204
99. Bouneaud C, Garcia Z, Kourilsky P, Pannetier C. 2005. Lineage relationships, homeostasis, and recall capacities of central-and effector-memory CD8 T cells in vivo. J. Exp. Med. 201(4):579-90
100. Neuenhahn M, Kerksiek KM, Nauerth M, Suhre MH, Schiemann M, et al. 2006. CD8α+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity 25(4):619-30
101. Verschoor A, Neuenhahn M, Navarini AA, Graef P, Plaumann A, et al. 2011. A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3. Nat. Immunol. 12(12):1194-201
102. Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315(5808):107-11
103. Hildner K, Edelson BT, PurthaWE, Diamond M, Matsushita H, et al. 2008. Batf3 deficiency reveals a critical role for CD8α+ dendritic cells in cytotoxic T cell immunity. Science 322(5904):1097-100
104. AhmedR,GrayD. 1996. Immunological memory and protective immunity: understanding their relation. Science 272(5258):54-60
105. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, et al. 2003. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat. Immunol. 4(3):225-34
106. Hikono H, Kohlmeier JE, Takamura S, Wittmer ST, Roberts AD, Woodland DL. 2007. Activation phenotype, rather than central-or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J. Exp. Med. 204(7):1625-36
107. Marshall HD, Chandele A, Jung YW, Meng H, Poholek AC, et al. 2011. Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4+ cell properties during viral infection. Immunity 35(4):633-46
108. Starbeck-Miller GR, Xue H-H, Harty JT. 2014. IL-12 and type I interferon prolong the division of activated CD8 T cells by maintaining high-affinity IL-2 signaling in vivo. J. Exp. Med. 211(1):105-20
109. Corbin GA, Harty JT. 2004. Duration of infection and antigen display have minimal influence on the kinetics of the CD4+ T cell response to Listeria monocytogenes infection. J. Immunol. 173(9):5679-87
110. Badovinac VP, Messingham KAN, Jabbari A, Haring JS, Harty JT. 2005. Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat. Med. 11(7):748-56
111. Kaech SM, Wherry EJ, Ahmed R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2(4):251-62
112. Gett AV, Sallusto F, Lanzavecchia A, Geginat J. 2003. T cell fitness determined by signal strength. Nat. Immunol. 4(4):355-60
113. Sallusto F, Geginat J, Lanzavecchia A. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22:745-63
114. Buchholz VR,Neuenhahn M, BuschDH. 2011.CD8+ Tcell differentiation in the aging immune system: until the last clone standing. Curr. Opin. Immunol. 23(4):549-54
115. Nelson RW, Beisang D, Tubo NJ, Dileepan T, Wiesner DL, et al. 2014. T cell receptor cross-reactivity between similar foreign and self peptides influences naive cell population size and autoimmunity. Immunity 42(1):95-107
116. Yager EJ, AhmedM,LanzerK,Randall TD,Woodland DL, BlackmanMA. 2008. Age-associated decline in T cell repertoire diversity leads to holes in the repertoire and impaired immunity to influenza virus. J. Exp. Med. 205(3):711-23
117. Schlub TE,Venturi V, Kedzierska K, WellardC,Doherty PC, et al. 2009. Division-linked differentiation can account for CD8+ T-cell phenotype in vivo. Eur. J. Immunol. 39(1):67-77
118. Schlub TE, Badovinac VP, Sabel JT, Harty JT, Davenport MP. 2010. Predicting CD62L expression during the CD8+ T-cell response in vivo. Immunol. Cell Biol. 88(2):157-64
119. Kalia V, Sarkar S, Subramaniam S, Haining WN, Smith KA, Ahmed R. 2010. Prolonged interleukin-2Rαexpression on virus-specific CD8+ T cells favors terminal-effector differentiation in vivo. Immunity 32(1):91-103
120. Pipkin ME, Sacks JA, Cruz-Guilloty F, Lichtenheld MG, BevanMJ, Rao A. 2010. Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. Immunity 32(1):79-90
121. Rao RR, Li Q, Gubbels Bupp MR, Shrikant PA. 2012. Transcription factor Foxo1 represses T-betmediated effector functions and promotes memory CD8+ T cell differentiation. Immunity 36(3):374-87
122. Kim MV, Ouyang W, Liao W, Zhang MQ, Li MO. 2013. The transcription factor Foxo1 controls central-memory CD8+ T cell responses to infection. Immunity 39(2):286-97
123. Hedrick SM, Michelini RH, Doedens AL, Goldrath AW, Stone EL. 2012. FOXO transcription factors throughout T cell biology. Nat. Rev. Immunol. 12(9):649-61
124. Reiner SL, Adams WC. 2014. Lymphocyte fate specification as a deterministic but highly plastic process. Nat. Rev. Immunol. 14(10):699-704
125. Hodgkin PD, DowlingMR, DuffyKR. 2014.Whythe immune system takes its chanceswith randomness. Nat. Rev. Immunol. 14(10):711
126. Chang JT, Palanivel VR, Kinjyo I, Schambach F, Intlekofer AM, et al. 2007. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 315(5819):1687-91
127. Chang JT, Ciocca ML, Kinjyo I, Palanivel VR,McClurkin CE, et al. 2011. Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity 34(4):492-504
128. Ciocca ML, Barnett BE, Burkhardt JK, Chang JT, Reiner SL. 2012. Cutting edge: asymmetric memory T cell division in response to rechallenge. J. Immunol. 188(9):4145-48
129. King CG, Koehli S, Hausmann B, Schmaler M, Zehn D, Palmer E. 2012. T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology. Immunity 37(4):709-20
130. FlossdorfM, R ossler J, Buchholz VR, Busch DH, H ofer T. 2015. CD8+ T cell diversification by asymmetric cell division. Nat. Immunol. 16(9):891-93
131. Arsenio J, Kakaradov B, Metz PJ, Kim SH, Yeo GW, Chang JT. 2014. Early specification of CD8+ T lymphocyte fates during adaptive immunity revealed by single-cell gene-expression analyses. Nat. Immunol. 15(4):365-72
132. Hawkins ED, Oliaro J, Kallies A, Belz GT, Filby A, et al. 2013. Regulation of asymmetric cell division and polarity by Scribble is not required for humoral immunity. Nat. Commun. 4:1801
133. Lemaître F, Moreau HD, Vedele L, Bousso P. 2013. Phenotypic CD8+ T cell diversification occurs before, during, and after the first T cell division. J. Immunol. 191(4):1578-85
134. Yamamoto R, Morita Y, Ooehara J, Hamanaka S, Onodera M, et al. 2013. Clonal analysis unveils self-renewing lineage-restricted progenitors generated directly from hematopoietic stem cells. Cell 154(5):1112-26
135. Mascre G, Dekoninck S, Drogat B, Youssef KK, Brohee S, et al. 2012. Distinct contribution of stem and progenitor cells to epidermal maintenance. Nature 489(7415):257-62
136. Hsu Y-C, Li L, Fuchs E. 2014. Transit-amplifying cells orchestrate stem cell activity and tissue regeneration. Cell 157(4):935-49
137. Weissman IL. 2000. Stem cells: units of development, units of regeneration, and units in evolution. Cell 100(1):157-68
138. Hale JS, Boursalian TE, Turk GL, Fink PJ. 2006. Thymic output in aged mice. PNAS 103(22):8447-52
139. Snyder CM, Cho KS, Bonnett EL, van Dommelen S, Shellam GR, Hill AB. 2008. Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity 29(4):650-59
140. Morrison SJ, ShahNM, Anderson DJ. 1997. Regulatorymechanisms in stem cell biology. Cell 88(3):287-98
141. Becker AJ, McCulloch EA, Till JE. 1963. Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature 197:452-54
142. Till JE, McCulloch EA, Siminovitch L. 1964. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. PNAS 51:29-36
143. Osawa M, Hanada K, Hamada H, Nakauchi H. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273(5272):242-45
144. Smith LG, Weissman IL, Heimfeld S. 1991. Clonal analysis of hematopoietic stem-cell differentiation in vivo. PNAS 88(7):2788-92
145. Etzrodt M, Endele M, Schroeder T. 2014. Quantitative single-cell approaches to stem cell research. Cell Stem Cell 15(5):546-58
146. Fearon DT, Manders P, Wagner SD. 2001. Arrested differentiation, the self-renewing memory lymphocyte, and vaccination. Science 293(5528):248-50
147. Gattinoni L, Klebanoff CA, Restifo NP. 2012. Paths to stemness: building the ultimate antitumour T cell. Nat. Rev. Cancer 12(10):671-84
148. Dykstra B, Kent D, Bowie M, McCaffrey L, Hamilton M, et al. 2007. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 1(2):218-29
149. Zhang Y, Joe G, Hexner E, Zhu J, Emerson SG. 2005. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat. Med. 11(12):1299-305
150. Gattinoni L, Zhong X-S, Palmer DC, Ji Y, Hinrichs CS, et al. 2009. Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells. Nat. Med. 15(7):808-13
151. Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17(10):1290-97
152. Kretzschmar K,Watt FM. 2012. Lineage tracing. Cell 148(1-2):33-45
153. Tischer D, Weiner OD. 2014. Illuminating cell signalling with optogenetic tools. Nat. Rev. Mol. Cell Biol. 15(8):551-58
154. Sun J, Ramos A, Chapman B, Johnnidis JB, Le L, et al. 2014. Clonal dynamics of native haematopoiesis. Nature 514(7522):322-27
155. Stemberger C, Dreher S, Tschulik C, Piossek C, Bet J, et al. 2012. Novel serial positive enrichment technology enables clinical multiparameter cell sorting. PLOS ONE 7(4):e35798
156. Shlush LI, Chapal-Ilani N, Adar R, Pery N, Maruvka Y, et al. 2012. Cell lineage analysis of acute leukemia relapse uncovers the role of replication-rate heterogeneity and microsatellite instability. Blood 120(3):603-12
157. Bachmann MF, Wolint P, Schwarz K, Jager P, Oxenius A. 2005. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L. J. Immunol. 175(7):4686-96
158. Pahl-Seibert M F, Juelch M, Podlech J, Thomas D, Deegen P, et al. 2005. Highly protective in vivo function of cytomegalovirus IE1 epitope-specificmemory CD8 T cells purified by T-cell receptor-based cell sorting. J. Virol. 79(9):5400-413
159. Huster KM, Stemberger C, Busch DH. 2006. Protective immunity towards intracellular pathogens. Curr. Opin. Immunol. 18(4):458-64
160. Huster KM, Stemberger C, Gasteiger G, Kastenm uller W, Drexler I, Busch DH. 2009. Cutting edge: Memory CD8 T cell compartment grows in size with immunological experience but nevertheless can lose function. J. Immunol. 183(11):6898-902
161. Taylor PC, Feldmann M. 2009. Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis. Nat. Rev. Rheumatol. 5(10):578-82
162. Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, et al. 2012. Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial. Lancet 380(9856):1829-39
163. Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, et al. 1995. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333(16):1038-44
164. Cobbold M, Khan N, Pourgheysari B, Tauro S, McDonald D, et al. 2005. Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers. J. Exp. Med. 202(3):379-86
165. Stemberger C, Graef P, Odendahl M, Albrecht J, D ossinger G, et al. 2014. Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy. Blood 124(4):628-37
166. Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, et al. 2011. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3(95):95ra73
167. Rambaldi A, Biagi E, Bonini C, Biondi A, Introna M. 2015. Cell-based strategies to manage leukemia relapse: efficacy and feasibility of immunotherapy approaches. Leukemia 29(1):1-10
168. Brentjens RJ, Davila ML, Riviere I, Park J, Wang X, et al. 2013. CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl. Med. 5(177):177ra38
169. Grupp SA, Kalos M, Barrett D, Aplenc R, Porter DL, et al. 2013. Chimeric antigen receptor-modified T cells for acute lymphoid leukemia. N. Engl. J. Med. 368(16):1509-18
170. Porter DL, Levine BL, Kalos M, Bagg A, June CH. 2011. Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365(8):725-33